Press Releases | Medtronic

Month Year

Email alerts

Jun 29, 2011

Medtronic Commends Congress and the Institute of Medicine on Study on Advancing Pain Research, Care and Education

MINNEAPOLIS, Jun 29, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today commended the U.S. Congress and the Institute of Medicine (IOM) of the National Academy of Sciences on the release of...
Jun 28, 2011

Medtronic Introduces an Innovative Mobile Application for the CareLink(R) Network

The CareLink(TM) Mobile Application Offers Direct Mobile Access to Data on the Medtronic CareLink(R) Network

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care...
Jun 28, 2011

Medtronic CEO Omar Ishrak Statement on rhBMP-2 Articles in Spine Journal

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Following is a statement from Omar Ishrak, chairman and chief executive officer of Medtronic, Inc. (NYSE: MDT) on a series of articles on recombinant...
Jun 25, 2011

Research Presented at ADA Adds to the Clinical Evidence for Medtronic's Sensor-Augmented Insulin Pump Therapy

STAR 3 Continuation Data, Low Glucose Suspend and Patient Reported Outcomes Highlighted at American Diabetes Association's 71st Scientific Sessions

SAN DIEGO, Jun 25, 2011 (BUSINESS WIRE) -- Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's...
Jun 23, 2011

Medtronic Board Increases Cash Dividend by Eight Percent; Increases Share Repurchase Plan

MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...
Jun 18, 2011

VALOR II Study Highlights Strengths of Valiant(R) Thoracic Stent Graft from Medtronic

Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study

MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...
Jun 13, 2011

Company Profile for Medtronic, Inc.

Company Profile for Medtronic, Inc. Jun 13, 2011 (BUSINESS WIRE) -- Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with...
Jun 3, 2011

Medtronic CFO Gary Ellis to Speak at Goldman Sachs Healthcare Conference

MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...
May 24, 2011

Medtronic Reports Fourth Quarter Earnings

Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%

MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...
May 24, 2011

Medtronic Provides Initial Revenue Outlook and EPS Guidance for Fiscal Year 2012

MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
May 20, 2011

Medtronic Resolute(R) Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

Late-breaker at EuroPCR Confirms Low Rates of Adverse Events with Novel Heart Device in More Than 5,000 Study Subjects

PARIS, May 20, 2011 (BUSINESS WIRE) -- A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong...
May 20, 2011

Positive Clinical Outcomes Reported with Medtronic CoreValve(R) System

Meta-Analysis of Seven International Clinical Registries Presented at EuroPCR 2011 Late-Breaking Presentation

PARIS, May 20, 2011 (BUSINESS WIRE) -- A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the...
May 19, 2011

Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach

New Access for Aortic Valve Replacement Achieves High Procedural Success in Italian Study of High Risk Patients

PARIS, May 19, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve(R) System,...
May 18, 2011

Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Clinical Data from Multiple Studies Presented at EuroPCR Show Next-Generation Device Delivers Excellent Safety and Efficacy in Challenging Patient Population

PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...
May 17, 2011

Medtronic CoreValve(R) Multi-Center Study Shows Rapid and Sustained Health-Related Quality-of-Life Improvements

Two-year Results from Europe and Canada Represent Longest-term Quality-of-life Assessment of All Transcatheter Aortic Valves to Date

PARIS, May 17, 2011 (BUSINESS WIRE) -- New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving...
May 16, 2011

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

EuroPCR Program Includes Endovascular Late-Breakers on IN.PACT Drug-Eluting Balloons and Mo.Ma Ultra Embolic Protection System Enrollment in IN.PACT SFA I DEB Study Completed; PIs for IN.PACT SFA II Study Selected

MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced...
May 16, 2011

Medtronic Launches Quick-to-Dough Bone Cement in the United States

Kyphon(R) Xpede(TM) Bone Cement Is the Latest Offering from Medtronic for Treatment of Spinal Fractures

MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate (PMMA) bone cement for...
May 13, 2011

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year Ended April 29, 2011

MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year end 2011 on Tuesday, May 24, 2011....
May 13, 2011

Vertebral Augmentation for Spinal Fractures Continues to Be Covered by Noridian Administrative Services

Kyphon(R) Balloon Kyphoplasty is Among Treatments that Continue to be Covered by Major Medicare Administrative Contractor

MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare...
May 12, 2011

Medtronic to Release New Clinical Data on Unrivaled Portfolio of Interventional Devices at EuroPCR

Highlights Include Late-Breakers and Other Scientific Sessions on CoreValve System, Resolute Drug-Eluting Stent, IN.PACT Drug-Eluting Balloons, Mo.Ma Embolic Protection System, and Renal Denervation with Symplicity Catheter System

MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) -- New clinical data on a range of innovative medical devices from Medtronic, Inc. (NYSE: MDT), to treat cardiac and vascular diseases - from severe...
May 10, 2011

Medtronic Board of Directors Announces Appointment of Omar Ishrak as Chairman and CEO

MINNEAPOLIS, May 11, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) announced today that its board of directors named Omar Ishrak as the company's new chairman and chief executive officer,...
May 9, 2011

Medtronic and Bayer HealthCare Expand International Alliance

MINNEAPOLIS & TARRYTOWN, N.Y., May 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will...
May 5, 2011

Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden in Symptomatic and Asymptomatic Patients Following RF Ablation

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...
May 5, 2011

New Data Shows Clinical Benefit of Cardiac Resynchronization Therapy (CRT) in Atrial Fibrillation (AF)

Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions,...
May 5, 2011

Medtronic Announces FDA Approval of Attain Ability(R) Plus and Attain Ability(R) Straight Left-Heart Leads for Cardiac Resynchronization Therapy (CRT) Devices

New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...

Show per page